HYPERTROPHIC CARDIOMYOPATHY TREATED BY INTERVENTIONAL TECHNIQUE - CASE REPORT

Authors

  • BRUNA CAROLLINE PESSOA ANDRADE INSTITUTO METROPOLITANO DE ENSINO SUPERIOR
  • MARCUS VINICIUS DE PAULA SILVA
  • FELIPE PORTO AGUIAR
  • JULIANA GUIMARÃES SOUZA YOST
  • DELFINO DA COSTA MACHADO FILHO

Keywords:

cardiomiopatia hipertrófica, alcoolização septal

Abstract

Cardiomiopatia hipertrófica é uma doença genética autossômica dominante caracterizada por hipertrofia ventricular na ausência de outras doenças que possam levar a essa alteração. A maioria dos pacientes são assintomáticos e tem seu diagnóstico suspeitado pela detecção de sopros cardíacos, alterações em eletrocardiograma ou investigações em famílias acometidas. Relato de caso: paciente do sexo feminino, 43 anos, procedente de Ibirité – MG, foi admitida na Santa Casa de BH com quadro de dor precordial provavelmente anginosa associada a dispneia aos mínimos esforços refratária ao tratamento clínico otimizado. Já sabidamente portadora de cardiomiopatia hipertrófica. O interessante deste caso consiste no fato de ilustrar que o método percutâneo de alcoolização septal é efetivo para abolir a obstrução sistólica na cardiomiopatia hipertrófica.

Downloads

Download data is not yet available.

Downloads

Published

19-10-2017

How to Cite

ANDRADE, B. C. P., SILVA, M. V. D. P., AGUIAR, F. P., YOST, J. G. S., & MACHADO FILHO, D. D. C. (2017). HYPERTROPHIC CARDIOMYOPATHY TREATED BY INTERVENTIONAL TECHNIQUE - CASE REPORT. Uningá Review, 32(1), 12–19. Retrieved from https://revista.uninga.br/uningareviews/article/view/44

Issue

Vol. 32 No. 1 (2017): UNINGA REVIEW JOURNAL

Section

Articles

License

I declare/we declare that the text submitted here is original, of my own authorship and does not infringe any type of third party rights. The content is my/our sole responsibility. Possible research involving animals and/or human beings is in accordance with Resolution 196/96 of the National Health Council and its complements. I declare that I am/we are in possession of the written consent of patients and that the research and its procedures were timely and adequately approved by the Ethics Committee of the institution of origin. We further declare that all institutional affiliations and all sources of financial support for the work are duly informed. I certify that there is no commercial or associative interest that represents a conflict of interest related to the submitted work. If there is commercial interest, in addition to the technical and academic ones, in the publication of the article, the information will be reported during the text.

Most read articles by the same author(s)